Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2020

View Archived Issues

New regeneration factor for muscle cells

Escape reports phase I data on oral S1P5 receptor agonist ESB-1609

Novel potent NAMPT inhibitor reduces tumor growth in mouse model of TNBC

SM-09419 shows promising antitumor activity in preclinical models of hematologic malignancies

New humanized transgenic mouse model of FNAIT

Apellis announces positive topline data from phase III PEGASUS study of pegcetacoplan in PNH

SX-682 blocks key immunosuppressive tumor cells

Galapagos synthesizes SIK1, SIK2 and SIK3 inhibitors

Canakkale Onsekiz Mart Ueniversitesi divulges EEF2K inhibitors

Georgia State University discloses compounds for bacterial infections

Scripps Research Institute presents myosin-2 ATPase activity inhibitors

Nanchang University identifies antibodies for enterovirus 71 infections

Cobra genome may yield new antivenoms, venom-based drugs

New CD7-negative T cells presented as potential treatment for CD7-positive cancer

CStone begins phase III study of CS-1001 for advanced esophageal squamous cell carcinoma

Takeda opens recruitment in phase II study of TAK-079 for generalized myasthenia gravis

Cerevel starts phase III study of tavapadon in early Parkinson's disease

Dosing begins in phase IIa trial of avasopasem manganese to reduce radiation-induced esophagitis

CureVac reports interim phase I data on prophylactic mRNA-based rabies vaccine CV-7202

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...